True...but trying to low-ball might be a huge gamble. It could ruin your chances of closing the deal. It could get rejected, or outbid by a competitor.
Or they could get a "white squire" (i.e. John Paulson etc) to get a controlling stake to ward off a black knight. There are theories that this happened in the spring with another stock I'm invested in (SGYP), where it is rumored that Allergan was attempting a hostile takeover, and Paulson simultaneously purchased 20-30 million shares to ward off a potentially low hostile takeover price.
Shareholders have to approve... Insiders hold a significant number of shares, institutions at this point show about 13%, and I doubt that they are over 20% at the end of the year.
Then we have the ATM offering which could also go to friendly hands if institutions start buying a lot
I don't think anyone will be pulling a fast one on Missling.